ADLINOD(lenalidomide)
Therapeutic class: immunomodulatory agent
Indication: Multiple Myeloma, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma
5mg, 10mg and 25 capsules
5mg:-
A bottle of 10 capsules10mg:-
A bottle of 10 capsules25mg:-
A bottle of 10 capsules- 20°C - 25°C (68°F - 77°F), Shelf Life: 2 Years
- As directed by the physician
